Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

SOPs for Analytical Method Development V 2.0

Analytical Method Development: SOP for HPTLC Method Development – V 2.0

Posted on By

To describe the procedure for the development and validation of High-Performance Thin Layer Chromatography (HPTLC) methods for qualitative and quantitative analysis of active pharmaceutical ingredients (APIs), excipients, and finished dosage forms.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Capillary Electrophoresis Method Development – V 2.0

Posted on By

This SOP outlines a systematic approach for the development and validation of Capillary Electrophoresis (CE) methods used in the separation, identification, and quantification of charged pharmaceutical compounds, impurities, and degradation products.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Ion Chromatography Method Development – V 2.0

Posted on By

To establish a detailed and standardized procedure for the development and validation of Ion Chromatography (IC) methods used to detect and quantify ionic impurities, including anions, cations, and organic acids, in pharmaceutical substances and dosage forms.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for DSC Method for Thermal Behavior Analysis – V 2.0

Posted on By

To define a standard procedure for developing and validating methods using Differential Scanning Calorimetry (DSC) for evaluating thermal behavior such as melting point, crystallinity, polymorphism, glass transition temperature (Tg), and excipient compatibility of pharmaceutical materials.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for TGA Method for Moisture and Volatile Content – V 2.0

Posted on By

To describe the procedure for the development and validation of Thermogravimetric Analysis (TGA) methods to quantitatively determine moisture content, volatile solvents, and decomposition profiles in pharmaceutical materials including APIs, excipients, and finished products.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for XRPD Method for Polymorph Characterization – V 2.0

Posted on By

To establish a detailed procedure for the development and validation of X-ray Powder Diffraction (XRPD) methods used in the identification, confirmation, and characterization of polymorphic forms in pharmaceutical substances.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for SEM Analysis of Particle Morphology – V 2.0

Posted on By

This SOP outlines the procedure for developing and validating Scanning Electron Microscopy (SEM) methods used to characterize the morphology, shape, and surface characteristics of pharmaceutical particles such as APIs, excipients, and formulations.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for TOC Method Development for Cleaning Validation – V 2.0

Posted on By

To establish a standard procedure for developing and validating a Total Organic Carbon (TOC) method for use in cleaning validation programs, ensuring trace-level detection of organic residues on manufacturing equipment surfaces following product changeovers or cleaning activities.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for Raman Spectroscopy Method Development – V 2.0

Posted on By

To establish a standard procedure for the development and validation of Raman spectroscopy methods used in the identification, characterization, and quantification of pharmaceutical raw materials, intermediates, and finished products.
Click to read the full article.

Analytical Method Development V 2.0

Analytical Method Development: SOP for NIR Method Development for In-Process Testing – V 2.0

Posted on By

This SOP defines the procedure for developing and validating Near Infrared (NIR) spectroscopy methods used for in-process testing (IPT) of pharmaceutical materials, focusing on real-time, non-destructive analysis of blend uniformity, moisture content, and identity verification.
Click to read the full article.

Analytical Method Development V 2.0

Posts pagination

Previous 1 … 15 16 17 … 38 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme